Besides, inhibiting CASC8 led to decreased development in non-small cell lung cancer and enhanced sensitivity against chemotherapy, implying CASC8 might be a novel target for cancer treatment in the future (Jiang et al., 2021). Here, CASC8 is linked to non-small cell lung carcinoma.